Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Queensland Health
McKesson
Federal Trade Commission
Express Scripts

Generated: July 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 5,665,727

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,665,727
Title: Use of 11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them
Abstract:The compounds of formula I, ##STR1## have been found to have excellent topical activity. They are thus indicated for use in the topical treatment of inflammatory and hyperpoliferative skin diseases and of cutaneous manifestations of immunologically-induced illnesses, such as psoriasis.
Inventor(s): Grassberger; Maximilian (Vienna, AT), Meingassner; Josef Gottfried (Perchtoldsdorf, AT), Stutz; Anton (Vienna, AT), Stutz; Peter (Vienna, AT)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:08/291,010
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 5,665,727
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 5,665,727

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,665,727

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Austria29527Nov 09, 1987
Germany37 42 805.5Dec 17, 1987

International Family Members for US Patent 5,665,727

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 400808 ➤ Sign Up
Austria 407957 ➤ Sign Up
Austria A273988 ➤ Sign Up
Austria A295287 ➤ Sign Up
Australia 2490288 ➤ Sign Up
Australia 619772 ➤ Sign Up
Switzerland 677448 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Queensland Health
McKinsey
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.